CTVA SEC Filings

Corteva, Inc. (CTVA) announced a significant settlement on September 9, 2026, resolving statewide PFAS claims and specific site-related issues in North Carolina. As part of this agreement, Corteva and its subsidiary EIDP, Inc. will collectively pay approximately $66 million over 15 years. This settlement is a component of a larger collective payment of $455 million by Corteva, EIDP, The Chemours Company, and DuPont de Nemours, Inc. to the State of North Carolina and its subdivisions. Furthermore, Corteva and DuPont will jointly guarantee Chemours' share of the settlement payments and establish a reserve fund of up to $135 million. This settlement also impacts the existing Memorandum of Understanding (MOU) among the parties. The North Carolina settlement payments will be applied against the MOU's $4 billion qualified spend cap, valued at their net present value ($210 million), and will satisfy future escrow contribution obligations, alleviating future cash requirements for these specific obligations.

Corteva, Inc. (CTVA) has filed an 8-K detailing a significant financing event related to its planned separation into two independent companies. The filing announces that Vylor Inc., a wholly owned subsidiary intended to house Corteva's seed business, has issued $1.1 billion in senior notes. These notes are split between $550 million due in 2031 with a 5.125% interest rate and $550 million due in 2036 with a 5.625% interest rate. The proceeds from this "Notes Offering" are earmarked to facilitate the separation by providing partial consideration for the seed business contribution to Vylor and to cover related transaction expenses, including potential exchanges of existing EIDP notes. This move signals progress towards the much-anticipated split, providing crucial funding for the creation of the new independent entities.

Corteva, Inc. (CTVA) has filed an 8-K detailing material definitive agreements related to its previously announced separation into two independent companies: one for crop protection and one for seeds (to be operated under Vylor Inc.). The key event is the commencement of private offers to exchange and consent solicitations for EIDP's outstanding senior notes. These offers are structured to allow holders of Corteva's existing EIDP Notes (2.300% Senior Notes due 2030, 5.125% Senior Notes due 2032, and 4.800% Senior Notes due 2033) to exchange them for new notes issued by Vylor. A significant development reported is that the necessary consents have been obtained to amend the EIDP Base Indenture and related supplemental indentures. These amendments will eliminate most restrictive covenants and change-of-control repurchase provisions, subject to the successful completion of the separation and the exchange offers. A fourth supplemental indenture has been entered into, which will become effective upon settlement of these transactions, marking a crucial step in restructuring the company's debt in anticipation of the spin-off.

Corteva, Inc. (CTVA) has filed an 8-K report on August 20, 2026, primarily to announce the issuance of a press release. While the specific details of the press release are not provided within the text of the 8-K itself, its inclusion as Exhibit 99.1 indicates that it contains material information relevant to investors. Investors should review Exhibit 99.1 for insights into recent developments, strategic announcements, or financial updates that may impact Corteva's business and stock performance.

Corteva, Inc. (CTVA) announced via an 8-K filing on August 14, 2026, that its subsidiary, Vylor, Inc., has filed its first amendment to its Form 10 registration statement. This filing is a critical step in Corteva's previously announced plan to separate its seed business into an independent, publicly traded company. The Form 10 provides investors with comprehensive details regarding Vylor's business operations, strategic direction, and historical financial performance, offering a clearer picture of the prospective standalone entity. This development is of significant interest to Corteva shareholders as it signals progress towards the separation. Investors should review the Vylor Form 10 to understand the distinct value proposition, risks, and opportunities associated with the new seed business entity. The cautionary statement highlights the inherent uncertainties and potential risks associated with such a spin-off, including impacts on personnel, customer relationships, and overall business operations, as well as the possibility that the transaction may not be consummated.

Corteva, Inc. (CTVA) has filed an 8-K to disclose details regarding exchange offers and consent solicitations related to its planned separation into two independent companies: one for crop protection and another for seeds, which will operate as Vylor Inc. The company is offering to exchange outstanding senior notes issued by its subsidiary EIDP, Inc. for new notes to be issued by Vylor. This move is a crucial step in the separation process, which is expected to be completed around October 1, 2026. Investors should note that the consent solicitations aim to eliminate substantially all restrictive covenants and events of default from the EIDP Base Indenture, and repurchase obligations upon a change of control from the supplemental indentures. This implies a significant alteration of the debt terms for existing EIDP noteholders. The company has also incorporated unaudited pro forma financial information for Vylor into this filing, providing a glimpse into the projected financial standing of the future seed business post-separation.

Corteva, Inc. reported net sales of $6.38 billion for the second quarter of 2026, a slight decrease of 1% compared to the prior year period, attributed to a 3% volume decrease, partly offset by a 1% increase in price and a 1% favorable currency impact. For the first six months of 2026, net sales increased by 4% to $11.28 billion, driven by favorable currency impacts, volume growth, and price increases. Net income attributable to Corteva for the second quarter of 2026 was $1.16 billion, or $1.73 per diluted share, a decrease from $1.31 billion, or $1.92 per diluted share, in the same period last year. This decline is influenced by various factors including increased restructuring charges and litigation settlements. The company announced its intention to separate into two independent, publicly traded companies focused on its Seed and Crop Protection businesses, a move expected to be a tax-free spin-off. Operationally, the Seed segment remained flat in net sales year-over-year for the quarter but saw a 6% increase in operating EBITDA. The Crop Protection segment experienced a 4% decrease in net sales but a 2% increase in operating EBITDA. The company is managing its liquidity through a combination of operating cash flow, credit facilities, and commercial paper, with total debt increasing significantly due to working capital needs and strategic payments.

Corteva, Inc. has filed an 8-K report on July 30, 2026, to announce its financial results for the second quarter ended June 30, 2026. While the specific financial figures are not detailed within the provided text of the 8-K, the filing indicates that the company is furnishing its press release and financial statement schedules, which are attached as Exhibits 99.1 and 99.2. Investors should refer to these exhibits for the detailed performance metrics, including revenue, profitability, and segment performance for the reported quarter. This filing serves as the official mechanism for Corteva to communicate its quarterly financial outcomes. The information provided is furnished and not deemed filed, meaning it does not carry the same regulatory implications as a formally filed document under Section 18 of the Exchange Act. Investors are encouraged to review Exhibits 99.1 and 99.2 for a comprehensive understanding of Corteva's financial condition and operational results for the period.

Corteva, Inc. has filed an 8-K report detailing significant changes related to its anticipated spin-off of the seed business into a new independent entity, Vylor, Inc. Key leadership transitions are underway, with four directors – Karen Grimes, Marcos Lutz, Charles Magro, and Kerry Preete – set to resign from Corteva's board. These resignations are effective upon the consummation of the spin-off and are a direct result of these individuals being slated to join the board of directors for Vylor. Importantly, the company states these departures are not due to any disagreements regarding Corteva's operations or policies, signaling a planned and strategic board reconfiguration for both entities post-separation. Furthermore, Corteva announced the formation of the post-separation boards for both Corteva and Vylor through separate press releases. This filing also confirms that Vylor has publicly filed its Form 10 registration statement with the SEC, providing detailed information about its business, strategy, and historical financials, which is now accessible to investors. These actions represent critical steps in Corteva's strategic plan to create two distinct, publicly traded companies, with the management and board structures being actively shaped to support their future independent operations.

Corteva, Inc. (CTVA) has announced an expanded scope for its multi-year footprint optimization and productivity initiative, referred to as the Crop Protection Operations Strategy Restructuring Program. The company has committed to the next phase of this program, which includes the intended cessation of production activities at its Asturias, Spain site, subject to consultation processes. Additionally, management has revised its previous estimates related to the exit of its Pittsburg, California production activities. These actions are expected to result in an aggregate pre-tax restructuring and asset-related charge of $750 million to $815 million, an increase of $100 million to $115 million from prior estimates. The charges are comprised of severance, asset-related impairments, and costs associated with exiting production and ceasing operations. Cash payments for these charges are projected to be between $400 million and $443 million, with the overall restructuring substantially complete by the end of 2028. Investors should monitor the outcomes of consultation processes and potential adjustments to these estimates.

Corteva, Inc. reported strong financial performance for the first quarter of 2026, with net sales increasing by 11% year-over-year to $4.9 billion, driven by a 6% volume increase, a 4% favorable currency impact, and a 1% price increase. This growth was observed across both the Seed and Crop Protection segments, with the Seed segment seeing a 12% increase in net sales and a 23% rise in segment operating EBITDA, and the Crop Protection segment reporting a 10% increase in net sales and a 15% rise in segment operating EBITDA. The company's profitability also improved, with net income attributable to Corteva increasing to $720 million from $652 million in the prior year quarter, resulting in diluted earnings per share of $1.07 compared to $0.95. Significant events during the quarter include the announcement of an intent to separate into two independent companies focused on Seed and Crop Protection businesses, alongside the initiation of "2026 Restructuring Actions" aimed at aligning the organizational structure for this separation, incurring $78 million in associated charges. The company also returned approximately $370 million to shareholders through share repurchases and dividends. While the company experienced a significant negative cash flow from operations of $(2.9) billion, largely due to a substantial increase in accounts and notes receivable and a large payment related to the Bayer dispute resolution, its liquidity position remains robust with approximately $6.7 billion in available credit facilities.

Corteva, Inc. (CTVA) has filed its Form 8-K on May 5, 2026, to report its consolidated financial results for the first quarter ended March 31, 2026. While the filing itself primarily serves to furnish these results and related schedules, it indicates that the company has officially announced its performance for the period. Investors should refer to the press release (Exhibit 99.1) and financial statement schedules (Exhibit 99.2) for detailed insights into revenue, profitability, and other key financial metrics. The filing emphasizes that the information furnished is not deemed "filed" for the purposes of Section 18 of the Exchange Act, meaning it does not carry the same liabilities as a formally filed document. However, it remains a crucial source of information for understanding the company's recent operational and financial standing. Investors are encouraged to examine the exhibits to gain a comprehensive understanding of Corteva's Q1 2026 performance and its implications for future strategic direction.

Corteva, Inc. (CTVA) filed an 8-K on May 1, 2026, reporting the results of its Annual Meeting of Stockholders held on April 28, 2026. The meeting saw a strong turnout, with 89.16% of outstanding shares represented. Key outcomes include the overwhelming election of all 12 nominated directors to the Board, the advisory approval of executive compensation, and the ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2026. The advisory vote on the frequency of executive compensation votes also resulted in a strong preference for an annual vote.

Corteva, Inc. (CTVA) announced on April 14, 2026, significant leadership appointments and transitions related to its previously announced tax-free spin-off of its seed business (SpinCo) and crop protection business (New Corteva). The filing details the executive leadership teams for both newly formed independent companies, effective at the spin-off. Notably, current CEO Charles V. Magro will lead SpinCo, while Luther ("Luke") Kissam, an experienced executive with a background at Albemarle Corporation, has been appointed CEO of New Corteva, effective at the spin-off. Mr. Kissam will join Corteva as CEO of the Crop Protection Business Unit on June 1, 2026, to oversee the transition. This leadership realignments marks a critical step towards the completion of the spin-off, aiming to create two distinct, publicly traded entities. Investors should pay close attention to the compensation packages for the new leadership, particularly Mr. Kissam's, which include a substantial base salary, incentive opportunities, and equity awards. The company also confirmed other key executive appointments for both SpinCo and New Corteva, and outlined a transitional role for Robert D. King, Executive Vice President of the Crop Protection Business Unit.

Corteva, Inc. reported robust performance for the year ended December 31, 2025, with net sales increasing by 3% to $17.4 billion, driven by a 1% rise in price and a 3% increase in volume. This growth was achieved despite a 1% unfavorable currency impact. The company demonstrated strong operational execution, with Cost of Goods Sold (COGS) decreasing to $9.2 billion due to cost-saving initiatives, raw material deflation, and lower commodity prices, partially offset by higher volumes. Income from continuing operations after taxes significantly improved to $1.2 billion from $863 million in the prior year, with Operating EBITDA rising to $3.8 billion from $3.4 billion. Key strategic priorities for Corteva include delivering top-tier technology, increasing market share in seed trait out-licensing, driving operational improvements, and completing the intended separation of its Seed and Crop Protection businesses into two standalone public companies by the second half of 2026. The company also returned approximately $1.5 billion to shareholders through share repurchases and dividends in 2025, underscoring its commitment to shareholder value. Corteva remains focused on innovation and deploying capital with discipline to drive organic and inorganic growth.

Corteva, Inc. (CTVA) has filed an 8-K on February 3, 2026, to report its financial results for the quarter and full year ended December 31, 2025. While the filing itself is brief and primarily an informational update, it signifies the release of the company's detailed financial performance for the period. Investors should refer to the furnished exhibits, specifically the Press Release (Exhibit 99.1) and Financial Statement Schedules (Exhibit 99.2), for comprehensive insights into the company's revenue, profitability, and other key financial metrics for the fiscal year 2025.

Corteva, Inc. reported a net loss of $320 million, or $0.47 per share, for the third quarter of 2025, a significant improvement from the prior year's loss of $524 million, or $0.76 per share. This turn-around was driven by a substantial increase in net sales, which grew 13% to $2.62 billion, fueled by a 12% volume increase and a favorable 2% currency impact, partially offset by a 1% price decline. The company's Seed segment showed particular strength, with net sales up 33% driven by early deliveries in Brazil and recovery in Argentina, while the Crop Protection segment also saw a 4% increase in net sales due to demand for new products. For the nine-month period, net sales increased by 4% to $13.49 billion, with net income reaching $1.65 billion, a significant improvement from $958 million in the prior year. This performance reflects strategic execution in both segments, with the Seed segment benefiting from strong pricing and volume growth and the Crop Protection segment seeing benefits from raw material deflation and productivity savings. The company also announced its intent to separate into two independent publicly traded companies, one focused on seeds and the other on crop protection, a move expected to unlock further value.

Corteva, Inc. (CTVA) has filed a Form 8-K on November 3, 2025, reporting its financial results for the quarter ended September 30, 2025. The filing primarily serves to announce these results, which are detailed in an accompanying press release (Exhibit 99.1) and financial statement schedules (Exhibit 99.2). Investors should note that this information is furnished and not deemed "filed" under Section 18 of the Exchange Act, meaning it does not carry the same liability implications, nor will it be automatically incorporated into future SEC filings unless explicitly referenced. While the specifics of the financial performance are contained within the exhibits, this 8-K signals the release of key quarterly data. Investors interested in Corteva's operational performance, profitability, and financial condition for the third quarter of 2025 will need to review the furnished press release and financial statements. The filing is a standard procedural step for publicly traded companies to disseminate material financial information to the market.

Corteva, Inc. (CTVA) has announced a significant strategic move to separate into two independent, publicly traded companies via a tax-free spin-off, as detailed in their 8-K filing dated October 1, 2025. This decision marks a pivotal moment for the company, aiming to unlock greater value and strategic focus for each new entity. Investors should pay close attention to the details of this separation as it will reshape the company's structure and potentially its market position. Further details regarding the spin-off and commentary on expected 2025 financial performance will be discussed during an investor call scheduled for October 1, 2025. While the specific financial outcomes of the separation are yet to be fully disclosed, the intent to create two distinct entities suggests a move towards enhancing operational efficiency, pursuing specialized growth strategies, and providing clearer investment profiles for each business segment. Investors will be looking for information on the go-to-market strategies and financial projections for both new companies.

Corteva, Inc. announced a significant leadership transition within its legal and public affairs functions. Cornel Fuerer, Senior Vice President, Chief Legal and Public Affairs Officer, will retire from his executive officer role effective September 15, 2025. While Mr. Fuerer will transition his public affairs oversight and corporate secretary duties to his successor by the end of 2025, he will continue to serve as a strategic advisor until sometime in 2026, ensuring a smooth handover. Taking over the Chief Legal Officer role is Jennifer A. Johnson, a seasoned legal executive with extensive experience in the chemical and life sciences industries. Her background includes significant roles at International Flavors & Fragrances Inc. (IFF) and DuPont de Nemours, Inc., where she gained direct experience with Corteva's former parent company and its seed business. This appointment signals a focus on strengthening the company's legal and compliance framework.

Corteva, Inc. reported a strong second quarter and first half of 2025, with net sales increasing by 6% and 3% respectively, driven by volume growth and price increases across both its Seed and Crop Protection segments. The company demonstrated improved profitability, with net income rising significantly compared to the prior year, reflecting effective cost management and productivity initiatives. Operating EBITDA also saw substantial year-over-year growth, underscoring operational efficiencies and strong market performance, particularly in North America. Corteva continues to return value to shareholders through share repurchases and dividends, and is actively managing its operational footprint with ongoing restructuring efforts in its Crop Protection segment expected to yield significant savings. While the company experienced some unfavorable currency impacts, its diverse geographic presence and product portfolio helped mitigate these effects. Corteva remains focused on innovation and strategic investments in research and development to support its long-term growth. The company's financial position appears robust, with ample liquidity and access to credit facilities to fund its operations and strategic initiatives. Investors will be closely monitoring the progress of the Crop Protection restructuring and the ongoing legal and environmental matters, which, while managed, represent potential areas of future impact.

Corteva, Inc. (CTVA) has filed an 8-K report on August 6, 2025, to announce its financial results for the second quarter ended June 30, 2025. The filing includes a press release and financial statement schedules, furnished as exhibits. This report provides investors with an update on the company's operational and financial performance during the recently concluded quarter. Investors should refer to the furnished exhibits (99.1 and 99.2) for detailed financial information, including revenue, earnings, segment performance, and any forward-looking guidance. While this information is being furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act, it is crucial for understanding Corteva's recent financial health and strategic positioning in the agricultural sector.

Corteva, Inc. reported a net income of $656 million for the first quarter of 2025, a significant increase from $423 million in the same period of the prior year. This improvement was driven by higher income from continuing operations, which rose to $667 million from $376 million. Diluted earnings per share also saw a substantial increase, reaching $0.95 compared to $0.60 year-over-year. Net sales for the quarter were $4,417 million, a slight decrease of 2% compared to $4,492 million in Q1 2024. This was primarily due to a 5% unfavorable currency impact, partially offset by a 2% increase in volume and a 1% increase in price. The company continues to navigate global economic conditions, including currency fluctuations, while focusing on operational efficiencies and strategic pricing. The company also returned approximately $385 million to shareholders through share repurchases and dividends.

Corteva, Inc. (CTVA) has filed a Current Report (8-K) on May 7, 2025, announcing its financial results for the quarter ended March 31, 2025. The filing primarily includes a press release and financial statement schedules, furnished as exhibits. Investors should note that this information is furnished and not deemed 'filed' for purposes of liability under the Securities Exchange Act of 1934, nor is it automatically incorporated into future SEC filings unless expressly referenced. The key takeaway for investors is the announcement of the company's performance in the first quarter of 2025. While the detailed financial figures are within the furnished exhibits (99.1 and 99.2), the 8-K itself signals the release of this crucial operational and financial data. Investors will need to consult the accompanying press release and financial statements for specific metrics such as revenue, earnings per share, segment performance, and any forward-looking guidance provided by the company.

Corteva, Inc. filed an 8-K on May 5, 2025, detailing the results of its Annual Meeting of Stockholders held on April 30, 2025. The meeting saw strong participation, with over 89% of outstanding shares represented. Key outcomes include the election of all 12 director nominees and an advisory vote to approve executive compensation, both of which passed with significant support from shareholders. Additionally, the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2025 was ratified by stockholders. These results indicate shareholder confidence in the current board of directors and management's compensation structure. The overwhelming ratification of the independent auditor suggests satisfaction with the company's financial reporting oversight. Investors can view these outcomes as stable governance and continued trust in the company's auditing process as Corteva moves forward.

Corteva, Inc. announced a change in its Board of Directors, with Dr. Rebecca Liebert resigning from her position effective February 28, 2025. Dr. Liebert's departure is attributed to her decision to pursue other opportunities and is not due to any disagreements with the company's management or policies. This change will result in a reduction of the Board's size from thirteen to twelve directors.

Corteva, Inc. reported net sales of $16.9 billion for the year ended December 31, 2024, a 2% decrease compared to the prior year. This decline was primarily attributed to a 1% decrease in price and a 3% unfavorable currency impact, partially offset by a 2% increase in volume. The company's Seed segment saw a 1% increase in net sales, driven by price gains and volume growth in key regions like Brazil and North America. Conversely, the Crop Protection segment experienced a 5% decrease in net sales due to lower pricing and unfavorable currency impacts, despite a 3% volume increase. The company returned approximately $1.5 billion to shareholders through share repurchases and dividends in 2024. Corteva is focused on delivering innovative technology, accelerating innovation to farmers, and deploying capital with discipline. Despite a slight revenue dip, Corteva demonstrated resilience through operational execution and strategic investments, such as the acquisitions of Stoller and Symborg in the biologicals space. The company continues to manage its cost structure effectively, with COGS decreasing by $391 million year-over-year, largely due to favorable currency effects and productivity actions. Looking ahead, Corteva remains committed to its value creation framework and delivering differentiated solutions to farmers.

Corteva, Inc. (CTVA) has filed an 8-K report on February 5, 2025, to announce its financial results for the fourth quarter and full year ended December 31, 2024. The report primarily serves as a notification of the release of their earnings press release and financial statement schedules, which are furnished as exhibits. Investors should refer to these furnished documents (Exhibits 99.1 and 99.2) for detailed information regarding the company's performance, financial condition, and any forward-looking statements or strategic updates. While this 8-K itself does not contain the financial details, it directs stakeholders to the official press release and detailed schedules for a comprehensive understanding of Corteva's 2024 performance and outlook. It's important to note that the information furnished in this report is not considered "filed" for the purposes of Section 18 of the Exchange Act, meaning it does not carry the same legal liabilities as officially filed documents. Investors should consult Exhibits 99.1 and 99.2 for the substantive financial and operational information.

Corteva, Inc. reported net sales of $2,326 million for the third quarter of 2024, a decrease of 10% compared to the same period in the prior year, primarily driven by an 8% decrease in price and a 5% unfavorable currency impact, partially offset by a 3% increase in volume. The company experienced a net loss of $521 million for the quarter, compared to a net loss of $318 million in the prior year quarter. For the first nine months of 2024, net sales decreased by 4% to $12,930 million, with a net income of $948 million compared to $988 million in the same period last year. The company is navigating a competitive pricing environment in Crop Protection, particularly in Latin America, and reduced corn planted area in Argentina impacted Seed volumes. Despite these challenges, Corteva continues to invest in R&D and is implementing cost and productivity initiatives. The company also announced a restructuring program for its Crop Protection network, expected to yield significant savings by 2027. Corteva's outlook for full-year 2024 anticipates net sales between $17.0 billion and $17.2 billion, with Operating EBITDA expected to be between $3.35 billion and $3.45 billion. The company remains committed to returning capital to shareholders through dividends and share repurchases.

Corteva, Inc. (CTVA) has filed an 8-K detailing its financial results for the quarter ended September 30, 2024, and providing an update on its Crop Protection Operations Strategy Restructuring Program. While the 8-K primarily furnishes the press release regarding Q3 2024 results (Exhibit 99.1), the more significant update for investors relates to the revised restructuring plan. Corteva now anticipates aggregate pre-tax restructuring and asset-related charges between $650 million and $700 million, an increase from previous estimates. This includes substantial asset-related and impairment charges, as well as costs associated with exiting production activities, primarily at the Pittsburg, California site.

Corteva, Inc. (CTVA) announced a significant leadership transition within its Seed business unit. Timothy Glenn, Executive Vice President of the Seed business unit, has notified the company of his intent to retire effective December 1, 2024. Mr. Glenn will continue to support the company as an advisor through February 2025 to ensure a smooth handover. To succeed Mr. Glenn, Corteva has appointed Judd O’Connor as the new Executive Vice President of the Seed business unit, also effective December 1, 2024. Mr. O’Connor brings extensive experience, having served as the company's Commercial President for North America since July 2022 and holding various leadership roles within the Seed business and its predecessor entities for over 25 years. This succession plan aims to leverage Mr. O'Connor's deep industry knowledge to continue driving growth and innovation in Corteva's crucial seed segment.

Corteva, Inc. reported solid results for the second quarter of 2024, demonstrating resilience and strategic execution. Net sales increased by 1% year-over-year to $6.112 billion, driven by a 2% price increase that offset a 1% unfavorable impact from portfolio and other changes, while volumes remained flat overall. The Seed segment showed particular strength, with net sales up 2% driven by strong pricing and a favorable product mix, contributing significantly to a 16% increase in segment operating EBITDA. This segment is outperforming the market and gaining share, underscoring the value of its advanced germplasm and trait technologies. While the Crop Protection segment's net sales were flat year-over-year, driven by increased volumes in certain areas offset by price declines and currency headwinds, its segment operating EBITDA decreased by 20%. This was attributed to competitive pricing and raw material cost inflation, despite productivity savings and volume growth. The company continues to navigate a challenging market environment in Crop Protection but expects elevated input costs to subside in the second half of 2024. Overall, Corteva reiterated its full-year 2024 outlook for net sales and Operating EBITDA, signaling confidence in its strategic direction and operational capabilities.

Corteva, Inc. (CTVA) filed an 8-K on July 31, 2024, reporting its financial results for the quarter ended June 30, 2024, and announcing a significant executive leadership change. While the filing provides details on financial performance, the primary focus for investors in this report is the transition in the Chief Financial Officer role. The company is also providing information on its Q2 2024 results via press releases, which are furnished as exhibits, but the core of the 8-K relates to personnel changes. The most impactful news for investors concerns the retirement of current CFO David J. Anderson, effective September 16, 2024, after a distinguished tenure. He will transition to an advisory role until February 2025. Succeeding him will be David P. Johnson, a seasoned executive with over 30 years of financial leadership experience, most recently at Atkore Inc. This transition represents a key moment for Corteva's financial strategy and execution moving forward.

Corteva, Inc. reported first quarter 2024 net sales of $4,492 million, a decrease of 8% compared to the prior year, primarily driven by a 9% decrease in volume, partially offset by a 3% increase in price. Net income attributable to Corteva was $419 million, or $0.60 per share, down from $595 million, or $0.84 per share, in the first quarter of 2023. The decline in earnings was influenced by lower sales volumes, increased R&D expenses, and higher restructuring charges related to the Crop Protection Operations Strategy Restructuring Program. The company is reaffirming its full-year 2024 outlook, expecting net sales between $17.4 billion and $17.7 billion and Operating EBITDA between $3.5 billion and $3.7 billion. Despite the year-over-year decline in the first quarter, management anticipates market growth in the second half of 2024, particularly in the Crop Protection segment, and continues to focus on cost and productivity improvements. Corteva also returned approximately $365 million to shareholders through share repurchases and dividends in the first quarter.

Corteva, Inc. (CTVA) filed an 8-K on May 1, 2024, reporting on its Annual Meeting of Stockholders held on April 26, 2024. The most significant event for investors is the approval and subsequent filing of an amendment to the Company's certificate of incorporation. This amendment permits the exculpation of officers, aligning with Delaware General Corporation Law, and became effective on May 1, 2024. While this primarily impacts corporate governance, it signifies management's focus on maintaining strong governance practices. The meeting also saw strong shareholder support for the election of all 13 director nominees and the ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2024. Additionally, shareholders approved, by advisory vote, the compensation of the named executive officers, indicating general confidence in the company's executive compensation strategy.

Corteva, Inc. (CTVA) has filed an 8-K report on May 1, 2024, to announce its consolidated financial results for the quarter ended March 31, 2024. The report primarily serves to furnish the company's press release and financial statement schedules, which contain the detailed financial performance information for the period. Investors should refer to Exhibits 99.1 and 99.2 for the specific figures and commentary regarding Corteva's operational and financial condition during the first quarter of 2024. While the 8-K itself does not contain the granular financial data, it directs stakeholders to the accompanying press release and schedules for comprehensive insights into revenue, profitability, segment performance, and any forward-looking statements or guidance provided by the company. The information is furnished, not filed, meaning it does not carry the same legal liabilities under Section 18 of the Exchange Act.

Corteva, Inc. reported net sales of $17.2 billion for the fiscal year 2023, a slight decrease of 1% compared to the previous year, primarily attributed to a 10% volume decline partially offset by a 7% price increase and a favorable portfolio impact from acquisitions. The company's operating EBITDA improved to $3.4 billion, driven by strong price execution and productivity initiatives. Corteva successfully integrated two biologicals companies, Stoller and Symborg, in early 2023, enhancing its crop protection portfolio. The company returned approximately $1.2 billion to shareholders through share repurchases and dividends in 2023, reflecting a commitment to capital deployment. Looking ahead to 2024, Corteva anticipates net sales between $17.4 billion and $17.7 billion and operating EBITDA between $3.5 billion and $3.7 billion, indicating confidence in continued growth and operational efficiency. Significant emphasis was placed on innovation and sustainability, with increased investment in R&D to deliver differentiated solutions. The company continues to manage risks associated with regulatory approvals, supply chain dynamics, and evolving market conditions, while also navigating ongoing litigation related to legacy EIDP businesses, particularly concerning PFAS matters.

Corteva, Inc. (CTVA) filed an 8-K on January 31, 2024, to report its financial results for the quarter and full year ended December 31, 2023. The filing includes a press release (Exhibit 99.1) and financial statement schedules (Exhibit 99.2), which contain the detailed financial performance information. Investors should refer to these exhibits for a comprehensive understanding of the company's operational and financial condition as of year-end 2023. While this 8-K primarily serves as a notification and furnishing of the financial results press release, it is crucial for investors to review the attached exhibits. These documents will provide insights into key performance indicators, revenue figures, profitability, and any forward-looking statements or management commentary regarding the company's outlook. The information furnished is not considered 'filed' for certain regulatory purposes, but it remains the primary source for understanding Corteva's latest financial standing.

Corteva, Inc. reported a net sales decline of 7% for the third quarter of 2023 compared to the prior year, driven primarily by a 15% decrease in volume, though partially offset by price increases and favorable currency impacts. For the first nine months of the year, net sales saw a slight decrease of 1%, also primarily due to lower volumes which were impacted by strategic product exits, inventory destocking, and delayed farmer purchases. The company has been investing in research and development, with an increase in R&D expenses year-over-year to support long-term growth. Significant progress has been made integrating the Stoller and Symborg acquisitions, which supplement the crop protection business with biological tools. Despite the sales volume challenges, Corteva's financial performance was supported by pricing strategies and cost management initiatives. The company is also actively managing its capital structure, including share repurchases and dividend payments.

Corteva, Inc. (CTVA) announced its third-quarter financial results for the period ending September 30, 2023, via an 8-K filing on November 8, 2023. While the filing primarily furnishes the earnings press release, a significant development disclosed is a plan to optimize its Crop Protection manufacturing network. This plan includes the closure of its Pittsburg, California site and ceasing operations on select manufacturing lines at other locations, anticipated to be substantially completed in 2024. This restructuring initiative is expected to incur pre-tax charges totaling $410 million to $460 million. These charges are composed of severance costs, asset impairments (notably $165-$175 million for the Pittsburg site's operating lease assets and property, plant, and equipment), and contract termination costs. The company anticipates future cash payments of $90 million to $120 million related to these charges, primarily for severance and contract termination obligations. Investors should monitor the impact of these restructuring efforts on future operational efficiency and financial performance.

Corteva, Inc. (CTVA) filed an 8-K on October 27, 2023, to furnish a press release announcing preliminary results for the quarter ended September 30, 2023, and updated full-year 2023 guidance. While specific financial figures are not detailed within the 8-K itself, these preliminary results and guidance updates are critical for investors to assess the company's recent performance and future outlook. The furnished press release (Exhibit 99.1) will contain the detailed sales and earnings figures, along with any revisions to previously provided financial expectations for the full year. Investors should pay close attention to the details in the accompanying press release to understand the drivers behind the quarter's performance and the reasoning for any changes in the full-year guidance. This includes analyzing segment-specific sales, profitability trends, and any commentary on market conditions that may have influenced these preliminary results. The information furnished in this report, while not deemed "filed" in the traditional sense, serves as an important communication channel for the company to provide timely updates to the market.

Corteva, Inc. reported net sales of $6.045 billion for the second quarter of 2023, a 3% decrease compared to the prior year, primarily driven by a 13% volume decline, partially offset by a 9% increase in price. The six-month period showed a 1% increase in net sales to $10.929 billion, with an 11% price increase offsetting a 9% volume decline. Net income for the quarter was $714 million ($1.00 per diluted share), down from $969 million ($1.33 per diluted share) in the same period last year. The company completed significant acquisitions of Stoller and Symborg in March 2023, integrating biological and microbiological technologies into its crop protection portfolio. Despite overall sales challenges, the company highlighted strong price execution and ongoing cost and productivity initiatives, while also managing increased interest expenses and investing in R&D.

Corteva, Inc. announced its second quarter 2023 financial results on August 3, 2023. The company reported its consolidated financial performance for the quarter ended June 30, 2023. Investors should refer to the press release (Exhibit 99.1) and financial statement schedules (Exhibit 99.2) furnished with this 8-K filing for detailed insights into the company's operational and financial condition during the period. This filing primarily serves to furnish the aforementioned financial information and does not constitute a formal filing under Section 18 of the Securities Exchange Act of 1934. Therefore, the liabilities associated with such a filing do not apply. The information presented is intended to be informative for stakeholders regarding Corteva's recent performance.

Corteva, Inc. (CTVA) announced through its subsidiary, EIDP, Inc., the successful issuance of $1.2 billion in aggregate principal amount of senior notes on May 15, 2023. This offering consisted of $600 million of 4.500% Senior Notes due 2026 and $600 million of 4.800% Senior Notes due 2033. The notes were issued under an existing indenture, supplemented by a second supplemental indenture, and were registered under the Securities Act of 1933. This debt issuance provides Corteva with additional capital, which can be utilized for various corporate purposes, potentially including general corporate operations, strategic investments, or refinancing existing debt. Investors should note the specific coupon rates and maturity dates to assess the company's cost of debt and its long-term financial obligations. The participation of major underwriters like Goldman Sachs, BofA Securities, and SMBC Nikko Securities indicates a standard and well-executed capital markets transaction.

Corteva, Inc. reported a net sales increase of 6% to $4.88 billion for the first quarter of 2023, driven by a 14% price increase, partially offset by a 4% volume decrease and a 5% unfavorable currency impact. Net income increased to $595 million, or $0.83 per diluted share, compared to $564 million, or $0.78 per diluted share, in the prior year's quarter. The company completed significant acquisitions of Stoller Group, Inc. and Quorum Vital Investment, S.L. (Symborg) for a combined $1.6 billion, strengthening its biologicals and microbiological technologies portfolio. Corteva also updated its full-year 2023 guidance, raising its net sales and Operating EBITDA expectations to reflect the impact of these acquisitions.

Corteva, Inc. (CTVA) filed an 8-K on May 3, 2023, to announce its first-quarter 2023 financial results. The filing indicates that the company's financial performance for the quarter ended March 31, 2023, was detailed in an accompanying press release and financial statement schedules, furnished as exhibits. Investors should note that this information is being furnished and not formally filed under Section 18 of the Exchange Act, meaning it does not carry the same liability. However, it provides a timely update on the company's operational and financial condition as of that period, offering insights into sales, profitability, and other key metrics relevant to understanding Corteva's recent performance in the agricultural sector.

Corteva, Inc. (CTVA) filed an 8-K on April 26, 2023, detailing the results of its Annual Meeting of Stockholders held on April 21, 2023. The primary purpose of the filing was to report the outcomes of shareholder votes on key corporate matters, including the election of directors, an advisory vote on executive compensation, and the ratification of the company's independent auditor. The meeting saw strong participation, with over 87% of outstanding shares represented. Key outcomes include the overwhelmingly approved election of all 13 director nominees, indicating shareholder confidence in the current board's leadership. Additionally, shareholders provided an advisory approval for the compensation of named executive officers. The appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2023 was also ratified by a significant majority, reinforcing the company's commitment to financial transparency and independent oversight.

Corteva, Inc. reported strong performance in 2022 with an 11% increase in net sales, reaching $17.5 billion, driven by robust price execution and volume growth across all regions. The company's Seed segment saw a 7% sales increase, primarily due to price hikes, while the Crop Protection segment experienced a significant 17% sales jump, fueled by both price increases and volume growth, particularly from new product introductions. Despite facing headwinds from unfavorable currency impacts and rising input costs, Corteva demonstrated effective cost management and productivity actions, leading to an improvement in Operating EBITDA by 25% to $3.2 billion. The company also returned approximately $1.4 billion to shareholders through share repurchases and dividends. Looking ahead to 2023, Corteva anticipates continued growth, projecting net sales between $18.1 billion and $18.4 billion and Operating EBITDA between $3.4 billion and $3.6 billion, signaling confidence in its strategic priorities and market position.

Corteva, Inc. (CTVA) filed an 8-K on February 1, 2023, to announce its financial results for the fourth quarter and full year ended December 31, 2022. The filing includes a press release and financial statement schedules, which provide details on the company's performance. While this report furnishes the information and is not deemed "filed" for liability purposes, it serves as a key communication to investors regarding the company's operational and financial standing. Investors should note that this 8-K primarily serves to announce these results, and the detailed forward-looking statements and risk factors are further elaborated in the company's Form 10-K and subsequent filings. The company emphasizes that actual results may differ materially from projections due to various risks and uncertainties, including those related to product development, regulatory approvals, market conditions, input cost volatility, and geopolitical events.

Corteva, Inc. (CTVA) filed an 8-K on December 21, 2022, to report on an amendment and restatement of its bylaws, effective December 15, 2022. The primary driver for these changes is to comply with new SEC regulations, specifically Rule 14a-19, which mandates the use of universal proxy cards in director election contests. The updated bylaws introduce specific procedural requirements for stockholders seeking to nominate directors, including stipulations on proxy solicitation and the use of proxy card colors. These amendments are designed to align Corteva's corporate governance with current regulatory standards and streamline certain administrative processes. While the changes are largely technical and driven by compliance, investors should note the increased burden on stockholders initiating proxy contests related to director nominations. Additionally, a procedural change was made to remove the requirement for the company to maintain a detailed list of stockholders for inspection at meetings, aligning with updated Delaware corporate law.